This is a study to evaluate the efficacy and safety of belzutifan monotherapy in participants with advanced pheochromocytoma/paraganglioma (PPGL), pancreatic neuroendocrine tumor (pNET), von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal St...
- Neoplasms
- Neuroendocrine Tumors
- Gastrointestinal Stromal Tumors
- Pheochromocytoma
- Adenoma, Islet Cell
- Paraganglioma
- Von Hippel-Lindau Disease
Age: 12 years - 66+
Gender: All